Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like SBI share sale probably to qualified investors: Arundhati Bhattacharya June 2, 2017 No inconsistency in number of taxpayers: CBDT August 18, 2017 Endress+Hauser announces CA76NA and CA80SI analyzers for power industry applications August 20, 2019